# Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID‐19: A retrospective study in two designated hospitals in Anhui, China

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lopinavir-ritonavir-and-interferon-combination-therapy-may-help-shorten-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yan Zuo,Yunlei Liu,Qi Zhong,Ke Zhang,Yuanhong Xu,Zhongxin Wang |
| Citations | 73 |
| DOI | 10.1002/jmv.26127 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.26127 |
| OpenAlex ID | https://openalex.org/W3032373103 |
| PMID | 32492211 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yan Zuo](https://scholariq.org/researchers/yan-zuo/)

## Paper primary topic

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

## Paper topics

- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [SARS-CoV-2 detection and testing](https://scholariq.org/topics/sars-cov-2-detection-and-testing/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.